Immunotherapy as a Downstaging Therapy for Liver Transplantation
Birgit Schwacha‐Eipper, Iulia Minciuna, Vanessa Banz, Jean François Dufour – 14 March 2020
Birgit Schwacha‐Eipper, Iulia Minciuna, Vanessa Banz, Jean François Dufour – 14 March 2020
Yankai Wen, Cynthia Ju – 14 March 2020
Anna Alvarez‐Guaita, Patricia Blanco‐Muñoz, Elsa Meneses‐Salas, Mohamed Wahba, Abigail H. Pollock, Jaimy Jose, Mercedes Casado, Marta Bosch, Rafael Artuch, Katharina Gaus, Albert Lu, Albert Pol, Francesc Tebar, Stephen E. Moss, Thomas Grewal, Carlos Enrich, Carles Rentero – 14 March 2020
Karen Man‐Fong Sze, Daniel Wai‐Hung Ho, Yung‐Tuen Chiu, Yu‐Man Tsui, Lo‐Kong Chan, Joyce Man‐Fong Lee, Kenneth Siu‐Ho Chok, Albert Chi‐Yan Chan, Chung‐Ngai Tang, Victor Wai‐Lun Tang, Irene Lai‐Oi Lo, Derek Tsz‐Wai Yau, Tan‐To Cheung, Irene Oi‐Lin Ng – 14 March 2020
Ling Xu, Jia Liu, Mengji Lu, Dongliang Yang, Xin Zheng – 14 March 2020 – The severe acute respiratory syndrome coronavirus 2 (SARS‐Cov‐2), the pathogen of 2019 novel coronavirus disease (COVID‐19), has posed a serious threat to global public health. The WHO has declared the outbreak of SARS‐CoV‐2 infection an international public health emergency. Lung lesions have been considered as the major damage caused by SARS‐CoV‐2 infection. However, liver injury has also been reported to occur during the course of the disease in severe cases.
Ling Xu, Jia Liu, Mengji Lu, Dongliang Yang, Xin Zheng – 14 March 2020 – The severe acute respiratory syndrome coronavirus 2 (SARS‐Cov‐2), the pathogen of 2019 novel coronavirus disease (COVID‐19), has posed a serious threat to global public health. The WHO has declared the outbreak of SARS‐CoV‐2 infection an international public health emergency. Lung lesions have been considered as the major damage caused by SARS‐CoV‐2 infection. However, liver injury has also been reported to occur during the course of the disease in severe cases.
Birgit Schwacha‐Eipper, Iulia Minciuna, Vanessa Banz, Jean François Dufour – 14 March 2020
Silvia Sookoian, Carlos J. Pirola, Luca Valenti, Nicholas O. Davidson – 14 March 2020 – Nonalcoholic fatty liver disease (NAFLD) represents a burgeoning worldwide epidemic whose etiology reflects multiple interactions between environmental and genetic factors. Here, we review the major pathways and dominant genetic modifiers known to be relevant players in human NAFLD and which may determine key components of the heritability of distinctive disease traits including steatosis and fibrosis.
Silvia Sookoian, Carlos J. Pirola, Luca Valenti, Nicholas O. Davidson – 14 March 2020 – Nonalcoholic fatty liver disease (NAFLD) represents a burgeoning worldwide epidemic whose etiology reflects multiple interactions between environmental and genetic factors. Here, we review the major pathways and dominant genetic modifiers known to be relevant players in human NAFLD and which may determine key components of the heritability of distinctive disease traits including steatosis and fibrosis.
Monika Sarkar, Deirdre Sawinski, Lisa Coscia, the American Society of Transplantation, Women’s Health Community of Practice – 14 March 2020